SCHEMBL30554282

SCHEMBL30554282

COC(=O)c1nc2cc3c(-c4ccncc4)nn(C(c4ccccc4)(c4ccccc4)c4ccccc4)c3cc2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 1/20 0.41
ALDH1A1 P00352 2/20 0.39
ATM Q13315 1/20 0.36
PKN1 Q16512 2/20 0.35
PKN2 Q16513 2/20 0.35
ABCB1 P08183 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
MAPK1 P28482 2/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
MAPK14 Q16539 2/20 0.34
MAPK13 O15264 1/20 0.34
ALOX5 P09917 1/20 0.34
GCGR P47871 1/20 0.34
MAPK12 P53778 1/20 0.34
MAPK11 Q15759 1/20 0.34
CDK5 Q00535 1/20 0.34
CDK5R1 Q15078 1/20 0.34
MAPT P10636 3/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20917255 1.00 RAF1 (0.41) RAF1ALDH1A1ATMPKN1PKN2
SCHEMBL22361080 0.90 PIN1 (0.36) RAF1ALDH1A1PKN1PKN2MAPK14
SCHEMBL22284224 0.90 PDE10A (0.37) ALDH1A1MAPK1MAPK14KDM4EPDE10A
SCHEMBL22284329 0.90 PDE10A (0.40) MAPK1PDE10A
SCHEMBL20920120 0.89 MAPK1 (0.35) ALDH1A1MAPK1MEN1KMT2AMAPT
SCHEMBL22284293 0.85 GSK3B (0.35) ALDH1A1MAPK1MAPTKDM4EPOLB
SCHEMBL22284160 0.85 TACR3 (0.34) RAF1ALDH1A1MAPK1MAPTKDM4E
SCHEMBL22284303 0.85 ROCK2 (0.42) ALDH1A1PKN2MAPK1MEN1KMT2A
SCHEMBL22284300 0.85 ROCK2 (0.42) ALDH1A1PKN2MAPK1MEN1KMT2A
SCHEMBL30554287 0.85 ROCK2 (0.42) ALDH1A1PKN2MAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112020357-B Salt of indazolyl-containing tricyclic derivative and crystal form thereof 上海翰森生物医药科技有限公司 2023-08-29 CN disclosed